BioCryst to Present New HAE Data from ORLADEYO® (berotralstat) and Navenibart at the 2026 European Academy of Allergy and Clinical Immunology Annual Meeting
BioCryst Pharmaceuticals Inc BCRX
$9.06
▼ -0.66%
($-0.06)
Open
$9.10
Prev Close
$9.12
Day Range
$8.91 – $9.15
52W Range
$6.00 – $11.31
Market Cap
$2.32B
P/E (TTM)
8.78
Beta
0.60
EPS (TTM)
$-1.78
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1994-03-04 |
| Shares Out. | 254,160,000 |
| Website | biocryst.com/ ↗ |
| Phone | 13026365400 |
BioCryst Pharmaceuticals Inc is a publicly traded company under the ticker symbol BCRX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
16 analysts (2026-05-01)